As COVID-19 spreads, it can be a reminder that science and health research are community efforts, and to optimize our opportunities for success and serendipity, we must open that community as widely as we can
A roundup of various insights from London-based data and analytics company GlobalData over the past couple months in multiple sectors of pharma, biotech and life sciences